LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 80

Search options

  1. Book ; Online: Good Research Practice in Non-Clinical Pharmacology and Biomedicine

    Bespalov, Anton / Michel, Martin C. / Steckler, Thomas

    (Handbook of Experimental Pharmacology ; 257)

    2020  

    Author's details edited by Anton Bespalov, Martin C. Michel, Thomas Steckler
    Series title Handbook of Experimental Pharmacology ; 257
    Keywords Pharmacology ; Neurosciences ; Cardiology ; Oncology
    Subject code 615
    Language English
    Size 1 Online-Ressource (X, 423 p. 34 illus., 21 illus. in color)
    Edition 1st ed. 2020
    Publisher Springer International Publishing ; Imprint: Springer
    Publishing place Cham
    Document type Book ; Online
    HBZ-ID HT020384379
    ISBN 978-3-030-33656-1 ; 9783030336554 ; 9783030336578 ; 9783030336585 ; 3-030-33656-5 ; 3030336557 ; 3030336573 ; 3030336581
    DOI 10.1007/978-3-030-33656-1
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Book ; Online: Good Research Practice in Non-Clinical Pharmacology and Biomedicine

    Bespalov, Anton / Michel, Martin C. / Steckler, Thomas

    2020  

    Abstract: This open access book, published under a CC BY 4.0 license in the Pubmed indexed book series Handbook of Experimental Pharmacology, provides up-to-date information on best practice to improve experimental design and quality of research in non-clinical ... ...

    Abstract This open access book, published under a CC BY 4.0 license in the Pubmed indexed book series Handbook of Experimental Pharmacology, provides up-to-date information on best practice to improve experimental design and quality of research in non-clinical pharmacology and biomedicine
    Keywords Medicine (General) ; Neurosciences. Biological psychiatry. Neuropsychiatry
    Size 1 electronic resource (423 pages)
    Publisher Springer Nature
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT020589688
    ISBN 9783030336561 ; 3030336565
    DOI 10.1007/978-3-030-33656-1
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Article ; Online: Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.

    Galankin, Timofey L / Bespalov, Anton Y / Moebius, Hans Y

    Journal of Alzheimer's disease : JAD

    2024  Volume 98, Issue 4, Page(s) 1483–1491

    Abstract: Background: The term Behavioral and Psychological Symptoms of Dementia (BPSD) covers a group of phenomenologically and medically distinct symptoms that rarely occur in isolation. Their therapy represents a major unmet medical need across dementias of ... ...

    Abstract Background: The term Behavioral and Psychological Symptoms of Dementia (BPSD) covers a group of phenomenologically and medically distinct symptoms that rarely occur in isolation. Their therapy represents a major unmet medical need across dementias of different types, including Alzheimer's disease. Understanding of the symptom occurrence and their clusterization can inform clinical drug development and use of existing and future BPSD treatments.
    Objective: The primary aim of the present study was to investigate the ability of a commonly used principal component analysis to identify BPSD patterns as assessed by Neuropsychiatric Inventory (NPI).
    Methods: NPI scores from the Aging, Demographics, and Memory Study (ADAMS) were used to characterize reported occurrence of individual symptoms and their combinations. Based on this information, we have designed and conducted a simulation experiment to compare Principal Component analysis (PCA) and zero-inflated PCA (ZI PCA) by their ability to reveal true symptom associations.
    Results: Exploratory analysis of the ADAMS database revealed overlapping multivariate distributions of NPI symptom scores. Simulation experiments have indicated that PCA and ZI PCA cannot handle data with multiple overlapping patterns. Although the principal component analysis approach is commonly applied to NPI scores, it is at risk to reveal BPSD clusters that are a statistical phenomenon rather than symptom associations occurring in clinical practice.
    Conclusions: We recommend the thorough characterization of multivariate distributions before subjecting any dataset to Principal Component Analysis.
    MeSH term(s) Humans ; Principal Component Analysis ; Alzheimer Disease/diagnosis ; Alzheimer Disease/psychology ; Behavioral Symptoms/diagnosis ; Behavioral Symptoms/etiology ; Aging ; Neuropsychological Tests
    Language English
    Publishing date 2024-04-05
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-231008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Back to the Future of Neuropsychopharmacology.

    Bespalov, Anton / van Gaalen, Marcel / Steckler, Thomas

    Advances in neurobiology

    2023  Volume 30, Page(s) 207–224

    Abstract: Disappointments in translating preclinical findings into clinical efficacy have triggered a number of changes in neuroscience drug discovery ranging from investments diverted to other therapeutic areas to reduced reliance on efficacy claims derived from ... ...

    Abstract Disappointments in translating preclinical findings into clinical efficacy have triggered a number of changes in neuroscience drug discovery ranging from investments diverted to other therapeutic areas to reduced reliance on efficacy claims derived from preclinical models. In this chapter, we argue that there are several existing examples that teach us on what needs to be done to improve the success rate. We advocate the reverse engineering approach that shifts the focus from preclinical efforts to "model" human disease states to pharmacodynamic activity as a common denominator in the journey to translate clinically validated phenomena to preclinical level and then back to humans. Combined with the research rigor, openness, and transparency, this reverse engineering approach is well set to bring new effective and safe medications to patients in need.
    MeSH term(s) Humans ; Translational Research, Biomedical ; Drug Discovery ; Neurosciences
    Language English
    Publishing date 2023-03-16
    Publishing country United States
    Document type Journal Article
    ISSN 2190-5215
    ISSN 2190-5215
    DOI 10.1007/978-3-031-21054-9_9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Pharmacology of Anxiety or Pharmacology of Elevated Plus Maze?

    Bespalov, Anton / Steckler, Thomas

    Biological psychiatry

    2021  Volume 89, Issue 12, Page(s) e73

    MeSH term(s) Anti-Anxiety Agents ; Anxiety/drug therapy ; Dopamine ; Elevated Plus Maze Test ; Interpeduncular Nucleus
    Chemical Substances Anti-Anxiety Agents ; Dopamine (VTD58H1Z2X)
    Language English
    Publishing date 2021-02-18
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 209434-4
    ISSN 1873-2402 ; 0006-3223
    ISSN (online) 1873-2402
    ISSN 0006-3223
    DOI 10.1016/j.biopsych.2020.11.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The EQIPD quality system - Assessment and certification procedures.

    Emmerich, Christoph H / Bernard, René / Steckler, Thomas / Bespalov, Anton

    Journal of neuroscience methods

    2023  Volume 403, Page(s) 110053

    Abstract: The EQIPD Quality System was designed with the ultimate mission to provide a framework to ensure the quality and integrity of non-regulated preclinical biomedical research. For research quality to be sustained over time, it is crucial to have continuous ... ...

    Abstract The EQIPD Quality System was designed with the ultimate mission to provide a framework to ensure the quality and integrity of non-regulated preclinical biomedical research. For research quality to be sustained over time, it is crucial to have continuous improvement mechanisms that routinely monitor the research-related processes and enable solutions for identified issues. The present article is focused on these monitoring and assessment procedures that make the EQIPD Quality System a fully functional 'system' (as opposed to a mere collection of guidelines, work instructions and policies). In this context, a critical instrument are the internal and external assessments of the EQIPD Quality System performance described in detail. The assessment procedures emphasize the unique nature of the EQIPD Quality System being user-friendly, flexible and fit-for-purpose. By undergoing the (voluntary) external EQIPD assessment (leading to the EQIPD certification after all EQIPD core requirements have been implemented), a research unit: (i) secures confidence in the quality of data generated, (ii) ensures continuous improvement of research processes, and (iii) obtains an independent seal of quality communicating commitment to best research practices to the research community.
    MeSH term(s) Biomedical Research ; Certification
    Language English
    Publishing date 2023-12-30
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 282721-9
    ISSN 1872-678X ; 0165-0270
    ISSN (online) 1872-678X
    ISSN 0165-0270
    DOI 10.1016/j.jneumeth.2023.110053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Enhancing quality in preclinical data: Of hot science and cool quality.

    Bespalov, Anton / Emmerich, Christoph / Gerlach, Björn

    Temperature (Austin, Tex.)

    2020  Volume 7, Issue 4, Page(s) 301–303

    Language English
    Publishing date 2020-09-02
    Publishing country United States
    Document type Editorial
    ISSN 2332-8940
    ISSN 2332-8940
    DOI 10.1080/23328940.2020.1801133
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A call for better understanding of target engagement in Tau antibody development.

    Bespalov, Anton / Courade, Jean-Philippe / Khiroug, Leonard / Terstappen, Georg C / Wang, Yipeng

    Drug discovery today

    2022  Volume 27, Issue 11, Page(s) 103338

    Abstract: Significant efforts have been channeled into developing antibodies for the treatment of CNS indications. Disappointment with the first generation of clinical Tau antibodies in Alzheimer's disease has highlighted the challenges in understanding whether an ...

    Abstract Significant efforts have been channeled into developing antibodies for the treatment of CNS indications. Disappointment with the first generation of clinical Tau antibodies in Alzheimer's disease has highlighted the challenges in understanding whether an antibody can reach or affect the target in the compartment where it is involved in pathological processes. Here, we highlight different aspects essential for improving translatability of Tau-based immunotherapy.
    Language English
    Publishing date 2022-08-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1324988-5
    ISSN 1878-5832 ; 1359-6446
    ISSN (online) 1878-5832
    ISSN 1359-6446
    DOI 10.1016/j.drudis.2022.103338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Editorial for special issue on mGluRs and cognition.

    Bespalov, Anton

    European journal of pharmacology

    2010  Volume 639, Issue 1-3, Page(s) 1

    MeSH term(s) Animals ; Cognition/physiology ; Humans ; Neurosciences ; Receptors, Metabotropic Glutamate/agonists ; Receptors, Metabotropic Glutamate/antagonists & inhibitors ; Receptors, Metabotropic Glutamate/metabolism
    Chemical Substances Receptors, Metabotropic Glutamate
    Language English
    Publishing date 2010-08-10
    Publishing country Netherlands
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2010.03.049
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?

    Bespalov, Anton / Steckler, Thomas

    Journal of neuroscience methods

    2017  Volume 300, Page(s) 4–9

    Abstract: There are many reasons why novel therapeutics fail in clinical trials but these failures are often attributed to lacking quality of preclinical data. These problems are not limited to any specific therapeutic area, academic or industrial research and are ...

    Abstract There are many reasons why novel therapeutics fail in clinical trials but these failures are often attributed to lacking quality of preclinical data. These problems are not limited to any specific therapeutic area, academic or industrial research and are due in large part to several generic factors influencing research quality (e.g., related to definition of pre-specified endpoints, principles of study design and analysis, biased reporting, and lack of proper training). Yet, neuroscience drug discovery is often said to be affected more than the other fields. Within neuroscience, behavioral studies are the most blamed for being poorly designed, underpowered and mis-reported and there are indeed several factors that may be rather unique for behavioral research, such as a multitude of environmental conditions that are difficult to control and that are often not reported, ethical concerns about in vivo research and the pressure to reduce animal numbers, contributing to under-powered studies, and the complexity of study design and analysis, creating too much room for post hoc data massaging and selective reporting. Also, the blood-brain barrier as a frequently neglected complicating factor has to be considered in CNS research. The importance of these factors is increasingly recognized and urgent efforts are needed to demonstrate that behavioral methods of preclinical neuroscience research deliver results that can be as robust as with the non-behavioral methods Until this goal is achieved, behavioral neuroscience and neuroscience in general may be losing young talent, CNS drug discovery may lack the needed investment and this field may indeed be amongst the most affected by the current preclinical data quality crisis.
    MeSH term(s) Animals ; Behavioral Research/standards ; Biomedical Research/standards ; Blood-Brain Barrier/drug effects ; Central Nervous System/drug effects ; Drug Discovery/standards ; Humans ; Neurosciences/standards
    Language English
    Publishing date 2017-10-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 282721-9
    ISSN 1872-678X ; 0165-0270
    ISSN (online) 1872-678X
    ISSN 0165-0270
    DOI 10.1016/j.jneumeth.2017.10.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top